TABLE 1.
EAR, mg/d |
RDA, mg/d |
|||||
Life-stage group | Males | Females | Males | Females | AI, mg/d | UL, mg/d |
0–6 mo | — | — | — | — | 2 | 4 |
7–12 mo | 2.5 | 2.5 | 3 | 3 | — | 5 |
1–3 y | 2.5 | 2.5 | 3 | 3 | — | 7 |
4–8 y | 4.0 | 4.0 | 5 | 5 | — | 12 |
9–13 y | 7.0 | 7.0 | 8 | 8 | — | 23 |
14–18 y | 8.5 | 7.3 | 11 | 9 | — | 34 |
19–50 y | 9.4 | 6.8 | 11 | 8 | — | 40 |
≥51 y | 9.4 | 6.8 | 11 | 8 | — | 40 |
Pregnancy | ||||||
14–18 y | — | 10.5 | — | 12 | — | 34 |
19–50 y | — | 9.5 | — | 11 | — | 40 |
Lactation | ||||||
14–18 y | — | 10.9 | — | 13 | — | 34 |
19–50 y | — | 10.4 | — | 12 | — | 40 |
AI, Adequate Intake; EAR, Estimated Average Requirement; UL, Tolerable Upper Intake Level (unless otherwise specified, the UL represents the total intake from food, water, and supplements). Data are from reference 39.